Elaine M. Hylek

58.9k total citations · 19 hit papers
252 papers, 31.2k citations indexed

About

Elaine M. Hylek is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Epidemiology. According to data from OpenAlex, Elaine M. Hylek has authored 252 papers receiving a total of 31.2k indexed citations (citations by other indexed papers that have themselves been cited), including 214 papers in Cardiology and Cardiovascular Medicine, 96 papers in Internal Medicine and 44 papers in Epidemiology. Recurrent topics in Elaine M. Hylek's work include Atrial Fibrillation Management and Outcomes (209 papers), Venous Thromboembolism Diagnosis and Management (96 papers) and Cardiac Arrhythmias and Treatments (83 papers). Elaine M. Hylek is often cited by papers focused on Atrial Fibrillation Management and Outcomes (209 papers), Venous Thromboembolism Diagnosis and Management (96 papers) and Cardiac Arrhythmias and Treatments (83 papers). Elaine M. Hylek collaborates with scholars based in United States, Canada and Sweden. Elaine M. Hylek's co-authors include Daniel E. Singer, Lori Henault, Alan S. Go, Yuchiao Chang, Joe V. Selby, Kathleen A. Phillips, Jack Ansell, Mark Crowther, Gualtiero Palareti and Alan K. Jacobson and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Elaine M. Hylek

246 papers receiving 30.0k citations

Hit Papers

Prevalence of Diagnosed Atrial Fibrillation in Adults 1994 2026 2004 2015 2001 2008 2004 2012 2015 1000 2.0k 3.0k 4.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prevalence of Diagnosed Atrial Fibrillation in Adults
    2001 4.8k citations Alan S. Go, Elaine M. Hylek et al. profile →
  2. Pharmacology and Management of the Vitamin K Antagonists
    2008 1.6k citations Jack Ansell, Elaine M. Hylek et al. CHEST Journal profile →
  3. The Pharmacology and Management of the Vitamin K Antagonists
    2004 1.1k citations Jack Ansell, Elaine M. Hylek et al. CHEST Journal profile →
  4. Oral Anticoagulant Therapy
    2012 1.1k citations Walter Ageno, Alexander Gallus et al. CHEST Journal profile →
  5. Idarucizumab for Dabigatran Reversal
    2015 981 citations Elaine M. Hylek, Jeffrey I. Weitz et al. profile →
  6. Effect of Intensity of Oral Anticoagulation on Stroke Severity and Mortality in Atrial Fibrillation
    2003 943 citations Elaine M. Hylek, Alan S. Go et al. profile →
  7. Grading Strength of Recommendations and Quality of Evidence in Clinical Guidelines
    2006 862 citations Elaine M. Hylek, Gary E. Raskob et al. CHEST Journal profile →
  8. Major Hemorrhage and Tolerability of Warfarin in the First Year of Therapy Among Elderly Patients With Atrial Fibrillation
    2007 769 citations Elaine M. Hylek, Carmella Evans‐Molina et al. Circulation profile →
  9. Thrombosis
    2014 744 citations Gary E. Raskob, Pantep Angchaisuksiri et al. profile →
  10. Risk Factors for Intracranial Hemorrhage in Outpatients Taking Warfarin
    1994 711 citations Elaine M. Hylek et al. profile →
  11. Antithrombotic Therapy for Atrial Fibrillation
    2012 697 citations Daniel E. Singer, Margaret C. Fang et al. CHEST Journal profile →
  12. The “Gender Gap” in Authorship of Academic Medical Literature — A 35-Year Perspective
    2006 653 citations Lori Henault, Elaine M. Hylek et al. profile →
  13. An Analysis of the Lowest Effective Intensity of Prophylactic Anticoagulation for Patients with Nonrheumatic Atrial Fibrillation
    1996 578 citations Elaine M. Hylek, Steven J. Skates et al. profile →
  14. Anticoagulation Therapy for Stroke Prevention in Atrial Fibrillation
    2003 553 citations Alan S. Go, Elaine M. Hylek et al. profile →
  15. Thrombosis: a major contributor to the global disease burden
    2014 344 citations Gary E. Raskob, Pantep Angchaisuksiri et al. profile →
  16. The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study
    2016 330 citations Ziad Hijazi, Johan Lindbäck et al. profile →
  17. The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation
    2015 314 citations Laine Thomas, Elaine M. Hylek et al. European Heart Journal profile →
  18. The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation
    2016 284 citations Ziad Hijazi, Johan Lindbäck et al. European Heart Journal profile →
  19. Milvexian for the Prevention of Venous Thromboembolism
    2021 162 citations Jeffrey I. Weitz, Walter Ageno et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elaine M. Hylek United States 79 24.3k 11.1k 4.6k 2.7k 2.2k 252 31.2k
Stuart J. Connolly Canada 100 42.2k 1.7× 11.2k 1.0× 5.2k 1.1× 4.6k 1.7× 2.1k 1.0× 474 47.0k
Jonathan L. Halperin United States 88 29.0k 1.2× 9.5k 0.9× 6.2k 1.4× 3.3k 1.2× 1.6k 0.7× 305 35.1k
Michael D. Ezekowitz United States 75 41.4k 1.7× 13.3k 1.2× 7.7k 1.7× 3.9k 1.4× 2.6k 1.2× 269 47.8k
Deirdre A. Lane United Kingdom 71 22.1k 0.9× 6.8k 0.6× 4.3k 0.9× 1.4k 0.5× 1.8k 0.8× 311 25.6k
John W. Eikelboom Canada 94 35.1k 1.4× 18.4k 1.7× 5.6k 1.2× 9.4k 3.5× 1.4k 0.7× 670 47.6k
Alan S. Go United States 93 25.3k 1.0× 4.9k 0.4× 6.5k 1.4× 5.6k 2.1× 2.8k 1.3× 483 47.4k
Jack Ansell United States 62 11.7k 0.5× 7.5k 0.7× 1.7k 0.4× 2.5k 0.9× 932 0.4× 225 16.4k
Basil S. Lewis Israel 52 20.1k 0.8× 6.9k 0.6× 2.9k 0.6× 8.6k 3.2× 2.2k 1.0× 278 28.0k
Kenneth W. Mahaffey United States 97 32.6k 1.3× 10.4k 0.9× 3.9k 0.9× 13.1k 4.8× 1.7k 0.8× 656 48.2k
Gunnar Gislason Denmark 85 15.7k 0.6× 3.0k 0.3× 4.2k 0.9× 5.4k 2.0× 1.1k 0.5× 926 31.4k

Countries citing papers authored by Elaine M. Hylek

Since Specialization
Citations

This map shows the geographic impact of Elaine M. Hylek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elaine M. Hylek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elaine M. Hylek more than expected).

Fields of papers citing papers by Elaine M. Hylek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elaine M. Hylek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elaine M. Hylek. The network helps show where Elaine M. Hylek may publish in the future.

Co-authorship network of co-authors of Elaine M. Hylek

This figure shows the co-authorship network connecting the top 25 collaborators of Elaine M. Hylek. A scholar is included among the top collaborators of Elaine M. Hylek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elaine M. Hylek. Elaine M. Hylek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peacock, James M., Lawrence C. Johnson, Elaine M. Hylek, et al.. (2024). Using Atrial Fibrillation Burden Trends and Machine Learning to Predict Near-Term Risk of Cardiovascular Hospitalization. Circulation Arrhythmia and Electrophysiology. 17(11). e012991–e012991. 2 indexed citations
2.
Piccini, Jonathan P., Elaine M. Hylek, Rahul Kanwar, et al.. (2024). Performance of Atrial Fibrillation Burden Trends for Stroke Risk Stratification. Circulation Arrhythmia and Electrophysiology. 17(11). e012394–e012394. 2 indexed citations
3.
Lakkireddy, Dhanunjaya, Andrea Russo, Elaine M. Hylek, et al.. (2024). Use of continuous cardiac monitoring to assess the influence of atrial fibrillation burden and patterns on patient symptoms and healthcare utilization: The DEFINE AFib study. Heart Rhythm O2. 5(12). 951–956. 1 indexed citations
4.
Go, Alan S., Sana M. Al‐Khatib, Patrice Desvigne‐Nickens, et al.. (2023). Research Opportunities in Stroke Prevention for Atrial Fibrillation: A Report From a National Heart, Lung, and Blood Institute Virtual Workshop. Stroke. 54(3). 4 indexed citations
5.
Pol, Tymon, Ziad Hijazi, Johan Lindbäck, et al.. (2021). Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas. Open Heart. 8(1). e001471–e001471. 7 indexed citations
6.
Renda, Giulia, Giuseppe Patti, Iréne Lang, et al.. (2019). Thrombotic and hemorrhagic burden in women: Gender-related issues in the response to antithrombotic therapies. International Journal of Cardiology. 286. 198–207. 21 indexed citations
7.
Alexander, Karen P., Marc A. Brouwer, Hillary Mulder, et al.. (2018). Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: Insights from the ARISTOTLE trial. American Heart Journal. 208. 123–131. 48 indexed citations
8.
Caterina, Raffaele De, Ulrika Andersson, John H. Alexander, et al.. (2016). History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial. American Heart Journal. 175. 175–183. 17 indexed citations
9.
Steinberg, Benjamin A., Sunghee Kim, Laine Thomas, et al.. (2015). Increased Heart Rate Is Associated With Higher Mortality in Patients With Atrial Fibrillation (AF): Results From the Outcomes Registry for Better Informed Treatment of AF (ORBIT‐AF). Journal of the American Heart Association. 4(9). e002031–e002031. 42 indexed citations
10.
Christersson, Christina, Lars Wallentin, Ulrika Andersson, et al.. (2014). The efficacy of apixaban compared to warfarin in patients with atrial fibrillation with high coagulation activity despite anticoagulant treatment. European Heart Journal. 35. 866–867. 1 indexed citations
11.
Hijazi, Ziad, Ulrika Andersson, Bernard J. Gersh, et al.. (2014). Interleukin-6 and C-reactive protein and risk for cardiovascular events and death in anticoagulated patients with atrial fibrillation. European Heart Journal. 35. 1115–1116. 1 indexed citations
12.
Held, Claes, Elaine M. Hylek, John H. Alexander, et al.. (2014). Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial. European Heart Journal. 36(20). 1264–1272. 124 indexed citations
13.
Angchaisuksiri, Pantep, A Blanco, Harry R. Büller, et al.. (2014). Thrombosis: A Major Contributor to Global Disease Burden. Seminars in Thrombosis and Hemostasis. 40(7). 724–735. 102 indexed citations
14.
Hylek, Elaine M.. (2013). Anticoagulation Therapy for Atrial Fibrillation. Seminars in Thrombosis and Hemostasis. 39(2). 147–152. 9 indexed citations
15.
Ageno, Walter, et al.. (2012). Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis. CHEST Journal. 141. 49 indexed citations
16.
Piccini, Jonathan P., DaJuanicia N. Holmes, Elizabeth Fraulo, et al.. (2011). Abstract 16415: Patterns of Atrial Fibrillation and Treatment Strategies Vary According to Provider Specialty Across Community Practice Settings: Findings From the ORBIT-AF Registry. Circulation. 124. 53–5. 2 indexed citations
17.
Piccini, Jonathan P., DaJuanicia N. Holmes, Winnie W. Nelson, et al.. (2011). Abstract 15347: Symptom Status and Treatment Strategy in Contemporary Management of Atrial Fibrillation: Findings From the ORBIT-AF Registry. Circulation. 124.
18.
Hylek, Elaine M., Carmella Evans‐Molina, Carol Shea, Lori Henault, & Susan Regan. (2007). Major Hemorrhage and Tolerability of Warfarin in the First Year of Therapy Among Elderly Patients With Atrial Fibrillation. Circulation. 115(21). 2689–2696. 769 indexed citations breakdown →
19.
García, David, Susan Regan, Mark Crowther, Robert A Hughes, & Elaine M. Hylek. (2005). Warfarin Maintenance Dosing Patterns in Clinical Practice. CHEST Journal. 127(6). 2049–2056. 176 indexed citations
20.
Hylek, Elaine M., Steven J. Skates, Mary A. Sheehan, & Daniel E. Singer. (1997). An Analysis of the Lowest Effective Intensity of Prophylactic Anticoagulation for Patients With Nonrheumatic Atrial Fibrillation. ACC Current Journal Review. 2(6). 87. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stuart J. Connolly Breakdown of academic impact, for papers by Jonathan L. Halperin Breakdown of academic impact, for papers by Michael D. Ezekowitz Breakdown of academic impact, for papers by Deirdre A. Lane Breakdown of academic impact, for papers by John W. Eikelboom Breakdown of academic impact, for papers by Alan S. Go Breakdown of academic impact, for papers by Jack Ansell Breakdown of academic impact, for papers by Basil S. Lewis Breakdown of academic impact, for papers by Kenneth W. Mahaffey Breakdown of academic impact, for papers by Gunnar Gislason
Rankless by CCL
2026